-
Something wrong with this record ?
Ossifying fibromyxoid tumours with lipomatous and cartilaginous differentiation: A diagnostic pitfall
N. Klubíčková, S. Billings, JKT. Dermawan, JF. Molligan, K. Fritchie
Language English Country England, Great Britain
Document type Journal Article, Case Reports
Grant support
Univerzita Karlova v Praze
Ministerstvo Školství, Mládeže a Tělovýchovy
PubMed
39704199
DOI
10.1111/his.15396
Knihovny.cz E-resources
- MeSH
- Cell Differentiation MeSH
- Cartilage pathology MeSH
- Diagnosis, Differential MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Lipoma * pathology diagnosis genetics MeSH
- Soft Tissue Neoplasms * pathology diagnosis genetics MeSH
- Fibroma, Ossifying * pathology diagnosis genetics MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Case Reports MeSH
AIMS: Ossifying fibromyxoid tumour is a rare mesenchymal neoplasm predominantly affecting adults characterised by a multinodular growth pattern and the presence of a fibrous pseudocapsule with areas of ossification. Prompted by the recognition of a non-ossifying ossifying fibromyxoid tumour with lipomatous differentiation which caused diagnostic difficulty, we sought to further explore cases of ossifying fibromyxoid tumour with non-osseous heterologous elements. METHODS AND RESULTS: A search of our institutional and consultation archives revealed three additional cases that demonstrated lipomatous components and two cases with cartilaginous differentiation. RNA-sequencing revealed fusions involving PHF1 (n = 4) or EPC1 (n = 1) in all (five of five) cases tested, including EPC1::PHC1 and JAZF1::PHF1 fusions, which have not been reported before in ossifying fibromyxoid tumour. CONCLUSION: These six cases expand the histomorphological spectrum of ossifying fibromyxoid tumour, introducing lipomatous differentiation as a hitherto undocumented feature. Awareness of these rare variants will ensure appropriate diagnosis and clinical management.
Bioptical Laboratory Pilsen Czech Republic
Department of Anatomic Pathology Mayo Clinic Rochester Minnesota USA
Department of Pathology and Laboratory Medicine Cleveland Clinic Cleveland Ohio USA
Department of Pathology Charles University Faculty of Medicine in Pilsen Pilsen Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25015984
- 003
- CZ-PrNML
- 005
- 20250731091417.0
- 007
- ta
- 008
- 250708s2025 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/his.15396 $2 doi
- 035 __
- $a (PubMed)39704199
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Klubíčková, Natálie $u Department of Pathology, Charles University, Faculty of Medicine in Pilsen, Pilsen, Czech Republic $u Bioptical Laboratory, Pilsen, Czech Republic $1 https://orcid.org/0000000244075544
- 245 10
- $a Ossifying fibromyxoid tumours with lipomatous and cartilaginous differentiation: A diagnostic pitfall / $c N. Klubíčková, S. Billings, JKT. Dermawan, JF. Molligan, K. Fritchie
- 520 9_
- $a AIMS: Ossifying fibromyxoid tumour is a rare mesenchymal neoplasm predominantly affecting adults characterised by a multinodular growth pattern and the presence of a fibrous pseudocapsule with areas of ossification. Prompted by the recognition of a non-ossifying ossifying fibromyxoid tumour with lipomatous differentiation which caused diagnostic difficulty, we sought to further explore cases of ossifying fibromyxoid tumour with non-osseous heterologous elements. METHODS AND RESULTS: A search of our institutional and consultation archives revealed three additional cases that demonstrated lipomatous components and two cases with cartilaginous differentiation. RNA-sequencing revealed fusions involving PHF1 (n = 4) or EPC1 (n = 1) in all (five of five) cases tested, including EPC1::PHC1 and JAZF1::PHF1 fusions, which have not been reported before in ossifying fibromyxoid tumour. CONCLUSION: These six cases expand the histomorphological spectrum of ossifying fibromyxoid tumour, introducing lipomatous differentiation as a hitherto undocumented feature. Awareness of these rare variants will ensure appropriate diagnosis and clinical management.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 12
- $a osifikující kostní fibrom $x patologie $x diagnóza $x genetika $7 D018214
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé středního věku $7 D008875
- 650 12
- $a nádory měkkých tkání $x patologie $x diagnóza $x genetika $7 D012983
- 650 12
- $a lipom $x patologie $x diagnóza $x genetika $7 D008067
- 650 _2
- $a diferenciální diagnóza $7 D003937
- 650 _2
- $a buněčná diferenciace $7 D002454
- 650 _2
- $a chrupavka $x patologie $7 D002356
- 650 _2
- $a senioři $7 D000368
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a kazuistiky $7 D002363
- 700 1_
- $a Billings, Steven $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA $1 https://orcid.org/0000000222785908
- 700 1_
- $a Dermawan, Josephine K T $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA $1 https://orcid.org/0000000211392914
- 700 1_
- $a Molligan, Jeremy F $u Department of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota, USA $1 https://orcid.org/0000000193061643
- 700 1_
- $a Fritchie, Karen $u Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, Ohio, USA $1 https://orcid.org/0009000938317496
- 773 0_
- $w MED00002043 $t Histopathology $x 1365-2559 $g Roč. 86, č. 6 (2025), s. 891-899
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39704199 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250708 $b ABA008
- 991 __
- $a 20250731091412 $b ABA008
- 999 __
- $a ok $b bmc $g 2366675 $s 1253109
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 86 $c 6 $d 891-899 $e 20241220 $i 1365-2559 $m Histopathology $n Histopathology $x MED00002043
- GRA __
- $p Univerzita Karlova v Praze
- GRA __
- $p Ministerstvo Školství, Mládeže a Tělovýchovy
- LZP __
- $a Pubmed-20250708